RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs.

MLA

Schmajuk, Gabriela, et al. “RISE Registry Reveals Potential Gaps in Medication Safety for New Users of Biologics and Targeted Synthetic DMARDs.” Seminars in Arthritis and Rheumatism, vol. 50, no. 6, Dec. 2020, pp. 1542–48. EBSCOhost, https://doi.org/10.1016/j.semarthrit.2020.03.003.

APA

Schmajuk, G., Li, J., Evans, M., Anastasiou, C., Izadi, Z., Kay, J. L., Hammam, N., & Yazdany, J. (2020). RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs. Seminars in Arthritis and Rheumatism, 50(6), 1542–1548. https://doi.org/10.1016/j.semarthrit.2020.03.003

Chicago

Schmajuk, Gabriela, Jing Li, Michael Evans, Christine Anastasiou, Zara Izadi, Julia L Kay, Nevin Hammam, and Jinoos Yazdany. 2020. “RISE Registry Reveals Potential Gaps in Medication Safety for New Users of Biologics and Targeted Synthetic DMARDs.” Seminars in Arthritis and Rheumatism 50 (6): 1542–48. doi:10.1016/j.semarthrit.2020.03.003.